A meta-analysis of efficacy in pre-clinical human stem cell therapies for traumatic brain injury

Experimental Neurology

Volumn 273, Issue , 2015, Pages 225-233

  Chang, Janessa ^a,b   Phelan, Michael ^a   Cummings, Brian J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell therapy; Cell transplantation; Meta analysis; Neurotrauma; Review; Scientific rigor; Stem cell therapy; Traumatic brain injury

Indexed keywords

ANIMAL MODEL; BEHAVIOR; DISEASE SEVERITY ASSESSMENT; EFFECT SIZE; HISTOPATHOLOGY; INFORMATION RETRIEVAL; META ANALYSIS (TOPIC); METHODOLOGY; MORRIS WATER MAZE TEST; NEUROLOGICAL SEVERITY SCORE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES; HUMAN; MEDLINE; META ANALYSIS; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; STEM CELL; TRANSLATIONAL RESEARCH;

ANIMALS; BRAIN INJURIES; HUMANS; PUBMED; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84941631870     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.08.020     Document Type: Review

References (40)

1. Anderson A.J., Haus D.L., Hooshmand M.J., Perez H., Sontag C.J., Cummings B.J. Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?. Regen. Med. 2011, 6:367-406.
2. CDC, Injury prevention & control: traumatic brain injury. URL: accessed on 09.04.2015. http://www.cdc.gov/TraumaticBrainInjury/.
3. Cook D., Julias M., Nauman E. Biological variability in biomechanical engineering research: significance and meta-analysis of current modeling practices. J. Biomech. 2014, 47:1241-1250.
4. Coronado V.G., Xu L., Basavaraju S.V., McGuire L.C., Wald M.M., Faul M.D., Guzman B.R., Hemphill J.D., Centers for Disease C.Prevention Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. Surveillance summaries 2011, 60:1-32.
5. Corrigan J.D., Selassie A.W., Orman J.A. The epidemiology of traumatic brain injury. J. Head Trauma Rehabil. 2010, 25:72-80.
6. Corso P., Finkelstein E., Miller T., Fiebelkorn I., Zaloshnja E. Incidence and lifetime costs of injuries in the United States. Inj. Prev. 2006, 12:212-218.
7. Cox C.S., Baumgartner J.E., Harting M.T., Worth L.L., Walker P.A., Shah S.K., Ewing-Cobbs L., Hasan K.M., Day M.C., Lee D., Jimenez F., Gee A. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 2011, 68:588-600.
8. Cummings B.J., Uchida N., Tamaki S.J., Salazar D.L., Hooshmand M., Summers R., Gage F.H., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14069-14074.
9. Cummings B.J., Uchida N., Tamaki S.J., Anderson A.J. Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol. Res. 2006, 28:474-481.
10. FDA Guidance for industry: preclinical assessment of investigational cellular and gene therapy products 2013.
11. Gold E.M., Su D., Lopez-Velazquez L., Haus D.L., Perez H., Lacuesta G.A., Anderson A.J., Cummings B.J. Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen. Med. 2013, 8:483-516.
12. Hooshmand M.J., Sontag C.J., Uchida N., Tamaki S., Anderson A.J., Cummings B.J. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One 2009, 4:e5871.
13. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J. Pharmacol. Pharmacother. 2010, 1:94-99.
14. Laird N.M., Mosteller F. Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care 1990, 6:5-30.
15. Landis S.C., Amara S.G., Asadullah K., Austin C.P., Blumenstein R., Bradley E.W., Crystal R.G., Darnell R.B., Ferrante R.J., Fillit H., Finkelstein R., Fisher M., Gendelman H.E., Golub R.M., Goudreau J.L., Gross R.A., Gubitz A.K., Hesterlee S.E., Howells D.W., Huguenard J., Kelner K., Koroshetz W., Krainc D., Lazic S.E., Levine M.S., Macleod M.R., McCall J.M., Moxley R.T., Narasimhan K., Noble L.J., Perrin S., Porter J.D., Steward O., Unger E., Utz U., Silberberg S.D. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012, 490:187-191.
16. Lees J.S., Sena E.S., Egan K.J., Antonic A., Koblar S.A., Howells D.W., Macleod M.R. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int. J. Stroke 2012, 7:582-588.
17. Lemmens R., Steinberg G.K. Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?. Curr. Opin. Neurol. 2013, 26:617-625.
18. Loane D.J., Faden A.I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 2010, 31:596-604.
19. Ludolph A.C., Bendotti C., Blaugrund E., Chio A., Greensmith L., Loeffler J.P., Mead R., Niessen H.G., Petri S., Pradat P.F., Robberecht W., Ruegg M., Schwalenstocker B., Stiller D., van den Berg L., Vieira F., von Horsten S. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph. Lateral Scler. 2010, 11:38-45.
20. Macleod M.R., O'Collins T., Howells D.W., Donnan G.A. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004, 35:1203-1208.
21. Menon D.K., Schwab K., Wright D.W., Maas A.I., Demographics, Clinical Assessment Working Group of the, I., Interagency Initiative toward Common Data Elements for Research on Traumatic Brain, I., Psychological, H. Position statement: definition of traumatic brain injury. Arch. Phys. Med. Rehabil. 2010, 91:1637-1640.
22. Nakagawa S., Santos E.S.A. Methodological issues and advances in biological meta-analysis. Evol. Ecol. 2012, 26:1253-1274.
23. NINDS, Improving the quality of NINDS-supported preclinical and clinical research through rigorous study design and transparent reporting in: Stroke, URL accessed on 09.04.2015. http://www.ninds.nih.gov/funding/transparency_in_reporting_guidance.pdf.
24. Olkin I. Statistical and theoretical considerations in metaanalysis. J. Clin. Epidemiol. 1995, 48:133-146.
25. Piltti K.M., Salazar D.L., Uchida N., Cummings B.J., Anderson A.J. Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy. Stem Cells Transl. Med. 2013, 2:204-216.
26. Piltti K.M., Salazar D.L., Uchida N., Cummings B.J., Anderson A.J. Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cells Transl. Med. 2013, 2:961-974.
27. Roet K.C., Bossers K., Franssen E.H., Ruitenberg M.J., Verhaagen J. A meta-analysis of microarray-based gene expression studies of olfactory bulb-derived olfactory ensheathing cells. Exp. Neurol. 2011, 229:10-45.
28. Salazar D.L., Uchida N., Hamers F.P., Cummings B.J., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010, 5:e12272.
29. Savitz S.I., Chopp M., Deans R., Carmichael T., Phinney D., Wechsler L., Participants S. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 2011, 42:825-829.
30. Shineman D.W., Basi G.S., Bizon J.L., Colton C.A., Greenberg B.D., Hollister B.A., Lincecum J., Leblanc G.G., Lee L.B., Luo F., Morgan D., Morse I., Refolo L.M., Riddell D.R., Scearce-Levie K., Sweeney P., Yrjanheikki J., Fillit H.M. Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res. Ther. 2011, 3:28.
31. Sontag C.J., Nguyen H.X., Kamei N., Uchida N., Anderson A.J., Cummings B.J. Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury. Stem Cells Transl. Med. 2013, 2:731-744.
32. Sontag C.J., Uchida N., Cummings B.J., Anderson A.J. Injury to the spinal cord niche alters the engraftment dynamics of human neural stem cells. Stem Cell Rep. 2014, 2:620-632.
33. (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009, 40:510-515. Stem Cell Therapies as an Emerging Paradigm in Stroke.
34. Stroke Therapy Academic Industry Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999, 30:2752-2758.
35. Tator C.H., Hashimoto R., Raich A., Norvell D., Fehlings M.G., Harrop J.S., Guest J., Aarabi B., Grossman R.G. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J. Neurosurg. Spine 2012, 17:157-229.
36. Team R.C. A Language and environment for statistical computing 2014, R Foundation for Statistical Computing, Vienna, Australia.
37. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999, 14:602-615.
38. Uchida N., Chen K., Dohse M., Hansen K.D., Dean J., Buser J.R., Riddle A., Beardsley D.J., Wan Y., Gong X., Nguyen T., Cummings B.J., Anderson A.J., Tamaki S.J., Tsukamoto A., Weissman I.L., Matsumoto S.G., Sherman L.S., Kroenke C.D., Back S.A. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci. Transl. Med. 2012, 4:155ra136.
39. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010, 36:1-48.
40. Vu Q., Xie K., Eckert M., Zhao W., Cramer S.C. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 2014, 82:1277-1286.